These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22451887)

  • 21. Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumors.
    Hanemaaijer R; Verheijen JH; Maguire TM; Visser H; Toet K; McDermott E; O'Higgins N; Duffy MJ
    Int J Cancer; 2000 Apr; 86(2):204-7. PubMed ID: 10738247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis.
    Rautelin HI; Oksanen AM; Veijola LI; Sipponen PI; Tervahartiala TI; Sorsa TA; Lauhio A
    Ann Med; 2009; 41(3):208-15. PubMed ID: 18979291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
    PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients.
    Farias E; Ranuncolo S; Cresta C; Specterman S; Armanasco E; Varela M; Lastiri J; Pallotta MG; Bal de Kier Joffe E; Puricelli L
    Int J Cancer; 2000 Jul; 89(4):389-94. PubMed ID: 10956415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
    Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
    Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expressions of Matrix Metalloproteinases 2, 7, and 9 in Carcinogenesis of Pancreatic Ductal Adenocarcinoma.
    Jakubowska K; Pryczynicz A; Januszewska J; Sidorkiewicz I; Kemona A; Niewiński A; Lewczuk Ł; Kędra B; Guzińska-Ustymowicz K
    Dis Markers; 2016; 2016():9895721. PubMed ID: 27429508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum and tissue expression of gelatinase and Twist in breast cancer.
    Huang J; Ang L; Liu MQ; Hu HG; Wang J; Zou Q; Zhao Y; Zheng L; Zhao M; Wu ZS
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2662-9. PubMed ID: 25317801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative levels of matrix metalloproteinase-7 and -9 and tissue inhibitor of matrix metalloproteinase-1 relation to pathologic parameters in bladder carcinoma patients.
    Gunes M; Kemik AS; Pirincci N; Gecit I; Taken K; Yuksel MB; Kaba M; Eryilmaz R
    Asian Pac J Cancer Prev; 2013; 14(2):873-6. PubMed ID: 23621254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low serum level of pro-matrix metalloproteinase 2 correlates with aggressive behavior in breast carcinoma.
    Kuvaja P; Talvensaari-Mattila A; Pääkkö P; Turpeenniemi-Hujanen T
    Hum Pathol; 2006 Oct; 37(10):1316-23. PubMed ID: 16949931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The matrix metalloproteinase-7 and pro-enzyme of metalloproteinase-1 as a potential marker for patients with rectal cancer without distant metastasis.
    Fuksiewicz M; Kotowicz B; Rutkowski A; Kowalska M
    Tumour Biol; 2015 May; 36(5):3629-35. PubMed ID: 25549795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma.
    Lein M; Jung K; Laube C; Hübner T; Winkelmann B; Stephan C; Hauptmann S; Rudolph B; Schnorr D; Loening SA
    Int J Cancer; 2000 Mar; 85(6):801-4. PubMed ID: 10709099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer.
    Daniele A; Zito AF; Giannelli G; Divella R; Asselti M; Mazzocca A; Paradiso A; Quaranta M
    Anticancer Res; 2010 Sep; 30(9):3521-7. PubMed ID: 20944132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of matrix metalloproteinases and their inhibitors with hypoxia and angiogenesis in premenopausal patients with adenocarcinoma of the breast.
    Vinothini G; Aravindraja C; Chitrathara K; Nagini S
    Clin Biochem; 2011 Aug; 44(12):969-74. PubMed ID: 21620816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix metalloproteinases MMP-2, MMP-7 and MMP-9 in denervated human muscle.
    Schoser BG; Blottner D
    Neuroreport; 1999 Sep; 10(13):2795-7. PubMed ID: 10511442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Zymography--method for quantitation of activity on gelatinase A (pro-MMP-2, 72 kDa) and gelatinase B (pro-MMP-9, 92 kDa) in serum of patients with breast cancer].
    Sliwowska I; Kopczyński Z
    Wiad Lek; 2007; 60(5-6):241-7. PubMed ID: 17966888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
    Goldbach-Mansky R; Lee JM; Hoxworth JM; Smith D; Duray P; Schumacher RH; Yarboro CH; Klippel J; Kleiner D; El-Gabalawy HS
    Arthritis Res; 2000; 2(2):145-53. PubMed ID: 11062605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum levels of matrix metalloproteinase 2 in patients with breast cancer.
    Sheen-Chen SM; Chen HS; Eng HL; Sheen CC; Chen WJ
    Cancer Lett; 2001 Nov; 173(1):79-82. PubMed ID: 11578812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast.
    Sullu Y; Demirag GG; Yildirim A; Karagoz F; Kandemir B
    Pathol Res Pract; 2011 Dec; 207(12):747-53. PubMed ID: 22030137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer.
    Shah FD; Shukla SN; Shah PM; Shukla HK; Patel PS
    Indian J Cancer; 2009; 46(3):194-202. PubMed ID: 19574670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer.
    Wu ZS; Wu Q; Yang JH; Wang HQ; Ding XD; Yang F; Xu XC
    Int J Cancer; 2008 May; 122(9):2050-6. PubMed ID: 18172859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.